Wasatch Global Investors released its third-quarter 2025 investor letter, noting strong US small-cap equities rally supported by the Fed Reserve’s interest rate cut. However, the fund-Investor Class struggled, ending the period down -3.17% vs. 12.19% gain for the Russell 2000 Growth Index. Check the fund’s top five holdings for 2025 picks.

Inspire Medical Systems, Inc. (NYSE:INSP) was highlighted in Wasatch Small Cap Growth Strategy’s third-quarter 2025 investor letter for its focus on minimally invasive solutions for obstructive sleep apnea. INSP had a one-month return of 53.98%, closing at $130.68/share on December 12, 2025, with a market cap of $3.865 billion.

Wasatch Small Cap Growth Strategy mentioned in its investor letter that Inspire Medical Systems, Inc. (NYSE:INSP) was sold during the quarter due to concerns about delays in the US commercial rollout of its next generation Inspire V system. The company’s shares slid after a downgrade in full-year 2025 guidance.

Inspire Medical Systems, Inc. (NYSE:INSP) was not among the 30 Most Popular Stocks Among Hedge Funds in Q3 2025, with 48 hedge fund portfolios holding positions in the company. INSP reported revenue of $224.5 million in Q3 2025, a 10% increase from the previous year. While INSP has investment potential, certain AI stocks may offer greater upside potential and lower downside risk.

Read more at Yahoo Finance: Inspire Medical Systems (INSP) Fell Following Reduced Full-Year Guidance